Home β€Ί Stories β€Ί Stocks
πŸ”΄ Fake hot

Eli Lilly Agrees to Pay Up to $3.8B for AtaiBeckley

ATAI surged 31% on acquisition announcement and is consolidating at a 4-year high.

Price at publication$7.22
Move+1.0%
Mentions9

What's happening

Eli Lilly announced it will pay up to $3.8 billion to acquire AtaiBeckley, the psychedelic pharmaceutical developer. Barron's reported the stock surged 31% on announcement day. The deal is among the largest acquisitions in the psychedelic drug space and marks Lilly's formal entry into the category as a therapeutic bet.

The numbers

ATAI at $7.22, up 0.98% in the current session β€” residual consolidation after the reported 31% announcement-day spike. Stock described across multiple sources as reaching a 4-year high. Chatter count 9.

Our read

The catalyst is real β€” Lilly committing up to $3.8B is not speculation. Today's muted move is consolidation after the announcement surge. At $7.22, the market is pricing some deal-close risk into the spread. Watch for formal merger agreement filings, FTC review timeline, and whether any competing bids emerge.

Sources we checked

See today's live board

This story is frozen as published on July 18, 2026. The live board shows what is moving right now, scored against real money.

Open this story live β†’ See today's live board

More Stocks stories

Research, not financial advice. Sort Brick reports what its data showed at the time of publication. It is not a recommendation to buy or sell anything β€” you decide.

Get Sort Brick Daily - free, every evening

One short email every evening: what really moved, what was only noise, and what we logged first, with the times. Free. Information, not investment advice.

No spam. One click to unsubscribe. Sent by Sort Brick.